News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
861,416 Results
Type
Article (87460)
Company Profile (760)
Press Release (773175)
Multimedia
Podcasts (175)
Webinars (28)
Section
Business (233063)
Career Advice (4140)
Deals (39797)
Drug Delivery (138)
Drug Development (91257)
Employer Resources (203)
FDA (18286)
Job Trends (17402)
News (397418)
Policy (39927)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (126)
Alliances (56980)
ALS (146)
Alzheimer's disease (1683)
Antibody-drug conjugate (ADC) (256)
Approvals (18317)
Artificial intelligence (499)
Autoimmune disease (80)
Automation (27)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (163)
Biotechnology (484)
Bladder cancer (135)
Brain cancer (53)
Breast cancer (514)
Cancer (4031)
Cardiovascular disease (343)
Career advice (3560)
Career pathing (38)
CAR-T (247)
CDC (57)
Cell therapy (689)
Cervical cancer (33)
Clinical research (75608)
Collaboration (1406)
Company closure (4)
Compensation (940)
Complete response letters (60)
COVID-19 (2959)
CRISPR (81)
C-suite (600)
Cystic fibrosis (139)
Data (4605)
Decentralized trials (2)
Denatured (63)
Depression (112)
Diabetes (455)
Diagnostics (7095)
Digital health (37)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (238)
Drug pricing (191)
Drug shortages (36)
Duchenne muscular dystrophy (204)
Earnings (98898)
Editorial (54)
Employer branding (25)
Employer resources (172)
Events (133111)
Executive appointments (994)
FDA (20790)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (15)
Funding (1271)
Gene editing (173)
Generative AI (50)
Gene therapy (549)
GLP-1 (1023)
Government (5386)
Grass and pollen (7)
Guidances (351)
Healthcare (20938)
HIV (48)
Huntington's disease (38)
IgA nephropathy (64)
Immunology and inflammation (244)
Immuno-oncology (21)
Indications (53)
Infectious disease (3206)
Inflammatory bowel disease (188)
Inflation Reduction Act (16)
Influenza (101)
Intellectual property (192)
Interviews (816)
IPO (17927)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (17)
Labor market (79)
Layoffs (641)
Leadership (36)
Legal (10148)
Liver cancer (92)
Longevity (13)
Lung cancer (580)
Lymphoma (267)
Machine learning (31)
Management (66)
Manufacturing (646)
MASH (141)
Medical device (14882)
Medtech (14907)
Mergers & acquisitions (22755)
Metabolic disorders (1164)
Multiple sclerosis (138)
NASH (23)
Neurodegenerative disease (230)
Neuropsychiatric disorders (62)
Neuroscience (2728)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (58)
Obesity (563)
Opinion (314)
Ovarian cancer (136)
Pain (168)
Pancreatic cancer (173)
Parkinson's disease (243)
Partnered (30)
Patents (423)
Patient recruitment (323)
Peanut (57)
People (66294)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23320)
Phase II (32822)
Phase III (24729)
Pipeline (2754)
Policy (295)
Postmarket research (3554)
Preclinical (10517)
Press Release (72)
Prostate cancer (202)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (682)
Real estate (7422)
Recruiting (79)
Regulatory (28049)
Reports (65)
Research institute (2692)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (74)
Schizophrenia (137)
Series A (211)
Series B (158)
Service/supplier (30)
Sickle cell disease (81)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4319)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (96)
The Weekly (110)
Vaccines (1054)
Venture capital (67)
Weight loss (397)
Women's health (59)
Worklife (21)
Date
Today (113)
Last 7 days (758)
Last 30 days (2730)
Last 365 days (33575)
2025 (26952)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1280)
Alabama (80)
Alaska (7)
Arizona (304)
Arkansas (14)
Asia (51005)
Australia (8963)
California (9570)
Canada (2887)
China (914)
Colorado (405)
Connecticut (427)
Delaware (271)
Europe (117184)
Florida (1407)
Georgia (316)
Hawaii (3)
Idaho (67)
Illinois (816)
India (52)
Indiana (466)
Iowa (20)
Japan (328)
Kansas (125)
Kentucky (38)
Louisiana (21)
Maine (78)
Maryland (1289)
Massachusetts (7180)
Michigan (315)
Minnesota (566)
Mississippi (4)
Missouri (122)
Montana (33)
Nebraska (26)
Nevada (109)
New Hampshire (79)
New Jersey (2653)
New Mexico (32)
New York (2599)
North Carolina (1421)
North Dakota (10)
Northern California (4350)
Ohio (300)
Oklahoma (22)
Oregon (50)
Pennsylvania (1987)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (50)
South Dakota (1)
Southern California (3653)
Tennessee (150)
Texas (1503)
United States (35308)
Utah (284)
Virginia (250)
Washington D.C. (84)
Washington State (824)
West Virginia (4)
Wisconsin (98)
Wyoming (1)
There are 861,416 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
GSK’s Blenrep Makes Comeback With FDA Nod for Third-Line Multiple Myeloma
The antibody-drug conjugate, withdrawn from the market by GSK in 2022 after failing a confirmatory study, was approved Thursday by the FDA for previously treated patients with multiple myeloma. This is despite a negative advisory committee vote in July.
October 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
NANOBIOTIX Announces Updates to JNJ-1900 (NBTXR3) Clinical Program Following Transfer of Ongoing Phase 3 Head and Neck Cancer Trial Sponsorship and Operational Control
October 24, 2025
·
5 min read
Press Releases
New Analysis of 13,560 Patients Demonstrates DecisionDx®-Melanoma Stratifies Risk Across Histological Subtypes; Findings to be Presented at Fall Clinical Dermatology Conference
October 24, 2025
·
8 min read
Press Releases
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production
October 24, 2025
·
4 min read
Press Releases
Vistin Pharma ASA: Invitation to Q3 2025 conference call
October 24, 2025
·
1 min read
Press Releases
Global Launch Event for iza-bren Phase III Nasopharyngeal Carcinoma Research Results Successfully Held, Streamed on ESMO Official Website
October 24, 2025
·
14 min read
Press Releases
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
October 24, 2025
·
2 min read
Press Releases
Cantargia to Participate in Upcoming November 2025 Conferences
October 24, 2025
·
1 min read
Press Releases
Telomir Pharmaceuticals Reports New Data Showing Telomir-1 Resets Cancer’s “Kill-and-Clean” Defense Systems in an Aggressive Prostate Cancer Model, Outperforming Rapamycin and Chemo
October 24, 2025
·
6 min read
Press Releases
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
October 24, 2025
·
1 min read
1 of 86,142
Next
